NCIt definition : The hydrochloride salt form of catequentinib, a receptor tyrosine kinase (RTK) inhibitor
with potential antineoplastic and anti-angiogenic activities. Upon administration,
catequentinib targets multiple RTKs, including vascular endothelial growth factor
receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis
and halt tumor cell growth.;
UNII : A3749M6582;
InChIKey : UUAKQNIPIXQZFN-UHFFFAOYSA-N;
CAS number : 1360460-82-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1360460-82-7
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;